Genomic alterations in lung adenocarcinoma
Top Cited Papers
- 1 July 2015
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 16 (7), e342-e351
- https://doi.org/10.1016/s1470-2045(15)00077-7
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor MaintenanceCancer Cell, 2013
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- A Landscape of Driver Mutations in MelanomaCell, 2012
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyThe Lancet Oncology, 2011
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- A small-cell lung cancer genome with complex signatures of tobacco exposureNature, 2009
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- The Hallmarks of CancerCell, 2000